Transcriptional repression of the anti-apoptotic survivin gene by wild type p53

被引:667
|
作者
Hoffman, WH
Biade, S
Zilfou, JT
Chen, JD
Murphy, M
机构
[1] Fox Chase Canc Ctr, Dept Pharmacol, Philadelphia, PA 19111 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Mol Oncol Program, Tampa, FL 33612 USA
关键词
D O I
10.1074/jbc.M106643200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survivin is a member of the inhibitor of apoptosis family. This apoptosis inhibitor also has an evolutionarily conserved role as a mitotic spindle checkpoint protein. Previous studies on p53-repressed genes have implicated several genes involved in the G(2)/M transition of the cell cycle as targets of negative regulation by p53. However, few targets of p53 repression that are antiapoptotic have been identified. This study identifies the anti-apoptotic survivin gene as a p53-repressed gene. Notably, Survivin repression by p53 is shown to be distinct from p53-dependent growth arrest. Chromatin immunoprecipitations indicate that p53 binds the survivin promoter in vivo; immunobinding studies indicate that this site overlaps with a binding site for E2F transcription factors and is subtly distinct from a canonical p53-transactivating element. The survivin-binding site contains a 3-nucleotide spacer between the two decamer "half-sites" of the p53 consensus element; deletion of this spacer is sufficient to convert the survivin site into a transactivating element. Finally, we show that overexpression of Survivin in cells sensitive to p53-dependent cell death markedly inhibits apoptosis induced by ultraviolet light. The identification of survivin as a p53 repressed gene should aid in the elucidation of the contribution of transcriptional repression to p53-dependent apoptosis.
引用
收藏
页码:3247 / 3257
页数:11
相关论文
共 50 条
  • [11] Repression of human reduced folate carrier gene expression by wild type p53
    Ding, BC
    Whetstine, JR
    Witt, TL
    Schuetz, JD
    Matherly, LH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) : 8713 - 8719
  • [12] Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome
    Badran, A
    Yoshida, A
    Wano, Y
    Mutoh, M
    Imamura, S
    Yamashita, T
    Tsutani, H
    Inuzuka, M
    Ueda, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 22 (01) : 59 - 64
  • [13] A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response
    Benatti, Paolo
    Basile, Valentina
    Merico, Daniele
    Fantoni, Luca Isaia
    Tagliafico, Enrico
    Imbriano, Carol
    NUCLEIC ACIDS RESEARCH, 2008, 36 (05) : 1415 - 1428
  • [14] The p53 response element and transcriptional repression
    Wang, Bei
    Xiao, Ziwei
    Ko, Hui Ling
    Ren, Ee Chee
    CELL CYCLE, 2010, 9 (05) : 870 - 879
  • [15] Myc upregulates anti-apoptotic protein, Survivin via a transcriptional activation
    Li, Hui
    Wei, Yun
    Tan, Yun
    Wu, Xinxing
    FASEB JOURNAL, 2008, 22
  • [16] Regulation of the tumor suppressor gene p53 and the cyclin dependent kinase, Cdc2, by survivin contributes to its anti-apoptotic effects.
    Wang, ZX
    Fukuda, S
    Mantel, C
    Pelus, LM
    BLOOD, 2003, 102 (11) : 354A - 354A
  • [17] Leptin Is an Anti-Apoptotic Effector in Placental Cells Involving p53 Downregulation
    Rayen Toro, Ayelen
    Lorena Maymo, Julieta
    Matias Ibarbalz, Federico
    Perez Perez, Antonio
    Maskin, Bernardo
    Graciela Faletti, Alicia
    Sanchez Margalet, Victor
    Laura Varone, Cecilia
    PLOS ONE, 2014, 9 (06):
  • [18] Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53
    Rho, Seung Bae
    Lee, Jeong Heon
    Park, Mi Sun
    Byun, Hyun-Jung
    Kang, Sokbom
    Seo, Sang-Soo
    Kim, Joo-Young
    Park, Sang-Yoon
    FEBS LETTERS, 2011, 585 (01) : 29 - 35
  • [19] Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection
    Megliorino, R
    Shi, FD
    Peng, XX
    Wang, X
    Chan, EKL
    Tan, EM
    Zhang, JY
    CANCER DETECTION AND PREVENTION, 2005, 29 (03): : 241 - 248
  • [20] INACTIVE P53 MUTANTS MAY ENHANCE THE TRANSCRIPTIONAL ACTIVITY OF WILD-TYPE P53
    ZHANG, W
    SHAY, JW
    DEISSEROTH, A
    CANCER RESEARCH, 1993, 53 (20) : 4772 - 4775